Neo Biopharm ApS

CVR number: 42875708
Kildegårdsvej 18 D, 2900 Hellerup

Income statement (kDKK)

20222023
Fiscal period length1212
Net sales
Gross profit2 458.30528.36
EBIT2 358.20335.15
Other financial expenses-16.27-19.04
Pre-tax profit2 341.93316.12
Income taxes- 517.02-72.31
Net earnings1 824.91243.80

Assets (kDKK)

20222023
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current trade debtors472.86
Current other receivables49.6658.98
Current deferred tax assets0.70
Short term receivables total523.2258.98
Cash and bank deposits2 069.432 686.29
Cash and cash equivalents2 069.432 686.29
Balance sheet total (assets)2 592.652 745.27

Equity and liabilities (kDKK)

20222023
Share capital40.0040.00
Retained earnings1 824.91
Profit of the financial year1 824.91243.80
Shareholders equity total1 864.912 108.71
Non-current liabilities total
Current trade creditors206.34564.25
Current owed to participating4.38
Short-term deferred tax liabilities517.0272.31
Current liabilities total727.74636.56
Balance sheet total (liabilities)2 592.652 745.27
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.